Fel d 1-airway inflammation prevention and treatment by co-immunization vaccine via induction of CD4+CD25-Foxp3+ Treg cells

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 5, 2013, Pages 1019-1031

  Pei, Yechun ^a   Geng, Shuang ^b   Liu, Lin ^a   Yan, Fengxiang ^a   Guan, Hong ^a   Hou, Jian ^a   Chen, Yongfu ^a   Wang, Bin ^b   An, Xiaorong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Airway inflammation; Co immunization; Fel d 1; T regulatory cell; Vaccine

Indexed keywords

ALLERGEN; FEL D 1 PROTEIN; INTERLEUKIN 10; PLASMID DNA; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGY; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; FE1 D 1 GENE; GENE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; LUNG LAVAGE; LUNG RESISTANCE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFLAMMATION;

AIRWAY INFLAMMATION; CO-IMMUNIZATION; FEL D 1; T REGULATORY CELL; VACCINE;

ANIMALS; ASTHMA; CATS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLYCOPROTEINS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; RHINITIS; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME; VACCINATION; VACCINES, DNA;

EID: 84878772395     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.23518     Document Type: Article

References (50)

1. Georas SN, Guo J, De Fanis U, Casolaro V. T-helper cell type-2 regulation in allergic disease. Eur Respir J 2005; 26:1119-37; PMID:16319345; http://dx.doi.org/10.1183/09031936.05.00006005.
2. Morgenstern JP, Griffith IJ, Brauer AW, Rogers BL, Bond JF, Chapman MD, et al. Amino acid sequence of Fel dI, the major allergen of the domestic cat: protein sequence analysis and cDNA cloning. Proc Natl Acad Sci U S A 1991; 88:9690-4; PMID:1946388; http://dx.doi.org/10.1073/pnas.88.21.9690.
3. Mata P, Charpin D, Charpin C, Lucciani P, Vervloet D. Fel d I allergen: skin and or saliva? Ann Allergy 1992; 69:321-2; PMID:1416268.
4. van Ree R, van Leeuwen WA, Bulder I, Bond J, Aalberse RC. Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy. J Allergy Clin Immunol 1999; 104:1223-30; PMID:10589005; http://dx.doi.org/10.1016/S0091-6749(99)70017-5.
5. Ohman JL Jr., Lowell FC, Bloch KJ. Allergens of mammalian origin. III. Properties of a major feline allergen. J Immunol 1974; 113:1668-77; PMID:4214862.
6. Hedlin G, Graff-Lonnevig V, Heilborn H, Lilja G, Norrlind K, Pegelow KO, et al. Immunotherapy with cat- and dog-dander extracts. II. In vivo and in vitro immunologic effects observed in a 1-year double-blind placebo study. J Allergy Clin Immunol 1986; 77:488-96; PMID:2419383; http://dx.doi.org/10.1016/0091- 6749(86)90184-3.
7. Hedlin G, Graff-Lonnevig V, Heilborn H, Lilja G, Norrlind K, Pegelow K, et al. Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment. J Allergy Clin Immunol 1991; 87:955-64; PMID:2026846; http://dx.doi.org/10.1016/0091-6749(91)90417-M.
8. Jin H, Kang Y, Zhao L, Xiao C, Hu Y, She R, et al. Induction of adaptive T regulatory cells that suppress the allergic response by coimmunization of DNA and protein vaccines. J Immunol 2008; 180:5360-72; PMID:18390718.
9. Jin H, Xiao C, Geng S, Hu Y, She R, Yu Y, et al. Protein/DNA vaccine-induced antigen-specific Treg confer protection against asthma. Eur J Immunol 2008; 38:2451-63; PMID:18792401; http://dx.doi.org/10.1002/eji. 200737899.
10. Kang Y, Jin H, Zheng G, Du X, Xiao C, Zhang X, et al. Co-inoculation of DNA and protein vaccines induces antigen-specific T cell suppression. Biochem Biophys Res Commun 2007; 353:1034-9; PMID:17204242; http://dx.doi.org/10.1016/j. bbrc.2006.12.124.
11. Jin H, Kang Y, Zheng G, Xie Q, Xiao C, Zhang X, et al. Induction of active immune suppression by coimmunization with DNA- and protein-based vaccines. Virology 2005; 337:183-91; PMID:15914231; http://dx.doi.org/10.1016/j. virol.2005.03.029.
12. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330-6; PMID:12612578; http://dx.doi.org/10.1038/ni904.
13. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001; 182:68-79; PMID:11722624; http://dx.doi.org/10.1034/j.1600-065X.2001.1820105.x.
14. Stock P, Akbari O, Berry G, Freeman GJ, Dekruyff RH, Umetsu DT. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004; 5:1149-56; PMID:15448689; http://dx.doi.org/10.1038/ni1122.
15. Zhang W, Jin H, Hu Y, Yu Y, Li X, Ding Z, et al. Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin. Hum Gene Ther 2010; 21:171-8; PMID:19788384; http://dx.doi.org/10.1089/hum.2009.095.
16. Li J, Jin H, Zhang F, Du X, Zhao G, Yu Y, et al. Treatment of autoimmune ovarian disease by coadministration with mouse zona pellucida protein 3 and DNA vaccine through induction of adaptive regulatory T cells. J Gene Med 2008; 10:810-20; PMID:18452236; http://dx.doi.org/10.1002/jgm.1200.
17. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102:157-64; PMID:9723654; http://dx.doi.org/10.1016/S0091-6749(98)70079-X.
18. Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004; 113:1025-34, quiz 1035; PMID:15208578; http://dx.doi.org/10.1016/j.jaci.2004.03.024.
19. Li J, Geng S, Xie X, Liu H, Zheng G, Sun X, et al. Caveolin-1-mediated negative signaling plays a critical role in the induction of regulatory dendritic cells by DNA and protein coimmunization. J Immunol 2012; 189:2852-9; PMID:22904311; http://dx.doi.org/10.4049/jimmunol.1102828.
20. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8:523-32; PMID:18566595; http://dx.doi.org/10.1038/nri2343.
21. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102:98-106; PMID:9649562; http://dx.doi.org/10.1172/JCI2250.
22. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199:1567-75; PMID:15173208; http://dx.doi.org/10.1084/jem. 20032058.
23. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363:608-15; PMID:14987885; http://dx.doi.org/10.1016/S0140-6736(04)15592-X.
24. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205-14; PMID:12731045; http://dx.doi.org/10.1002/eji.200322919.
25. Verhoef A, Alexander C, Kay AB, Larché M. T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med 2005; 2:e78; PMID:15783262; http://dx.doi.org/10.1371/journal.pmed.0020078.
26. Wei W, Liu Y, Wang Y, Zhao Y, He J, Li X, et al. Induction of CD4+CD25+Foxp3+IL-10+ T cells in HDM-allergic asthmatic children with or without SIT. Int Arch Allergy Immunol 2010; 153:19-26; PMID:20357481; http://dx.doi.org/10.1159/000301575.
27. Su W, Zhong W, Zhang Y, Xia Z. Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells. BMC Immunol 2012; 13:34; PMID:22769043; http://dx.doi.org/10.1186/1471-2172-13- 34.
28. Wang W, Xiang L, Liu YG, Wang YH, Shen KL. Effect of house dust mite immunotherapy on interleukin-10-secreting regulatory T cells in asthmatic children. Chin Med J (Engl) 2010; 123:2099-104; PMID:20819549.
29. Geng S, Yu Y, Kang Y, Pavlakis G, Jin H, Li J, et al. Efficient induction of CD25- iTreg by co-immunization requires strongly antigenic epitopes for T cells. BMC Immunol 2011; 12:27; PMID:21542943; http://dx.doi.org/10.1186/1471- 2172-12-27.
30. Counsell CM, Bond JF, Ohman JL Jr., Greenstein JL, Garman RD. Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat. J Allergy Clin Immunol 1996; 98:884-94; PMID:8939151; http://dx.doi.org/10. 1016/S0091-6749(96)80004-2.
31. Mark PG, Segal DB, Dallaire ML, Garman RD. Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects. Clin Exp Allergy 1996; 26:1316-28; PMID:8955581; http://dx.doi.org/10.1111/j.1365-2222. 1996.tb00529.x.
32. Reefer AJ, Carneiro RM, Custis NJ, Platts-Mills TAE, Sung SSJ, Hammer J, et al. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol 2004; 172:2763-72; PMID:14978075.
33. Kaiser L, Grönlund H, Sandalova T, Ljunggren HG, van Hage-Hamsten M, Achour A, et al. The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family. J Biol Chem 2003; 278:37730-5; PMID:12851385; http://dx.doi.org/10.1074/jbc.M304740200.
34. Grönlund H, Bergman T, Sandström K, Alvelius G, Reininger R, Verdino P, et al. Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli. J Biol Chem 2003; 278:40144-51; PMID:12732623; http://dx.doi.org/10.1074/ jbc.M301416200.
35. Kaiser L, Velickovic TC, Badia-Martinez D, Adedoyin J, Thunberg S, Hallén D, et al. Structural characterization of the tetrameric form of the major cat allergen Fel d 1. J Mol Biol 2007; 370:714-27; PMID:17543334; http://dx.doi.org/10.1016/j.jmb.2007.04.074.
36. Luczynska CM, Li Y, Chapman MD, Platts-Mills TA. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus). Measurements using cascade impactor, liquid impinger, and a two-site monoclonal antibody assay for Fel d I. Am Rev Respir Dis 1990; 141:361-7; PMID:2301854.
37. Custovic A, Green R, Fletcher A, Smith A, Pickering CA, Chapman MD, et al. Aerodynamic properties of the major dog allergen Can f 1: distribution in homes, concentration, and particle size of allergen in the air. Am J Respir Crit Care Med 1997; 155:94-8; PMID:9001295.
38. Saarne T, Kaiser L, Grönlund H, Rasool O, Gafvelin G, van Hage-Hamsten M. Rational design of hypoallergens applied to the major cat allergen Fel d 1. Clin Exp Allergy 2005; 35:657-63; PMID:15898990; http://dx.doi.org/10.1111/j.1365-2222.2005.02234.x.
39. Keating KM, Segal DB, Craig SJ, Nault AK, Semensi V, Wasserman AS, et al. Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d I recombinant chains. Mol Immunol 1995; 32:287-93; PMID:7723774; http://dx.doi.org/10.1016/0161-5890(94)00140-V.
40. Van Metre TE Jr., Marsh DG, Adkinson NF Jr., Fish JE, Kagey-Sobotka A, Norman PS, et al. Dose of cat (Felis domesticus) allergen 1 (Fel d 1) that induces asthma. J Allergy Clin Immunol 1986; 78:62-75; PMID:3722635; http://dx.doi.org/10.1016/0091-6749(86)90116-8.
41. Marcotte GV, Braun CM, Norman PS, Nicodemus CF, Kagey-Sobotka A, Lichtenstein LM, et al. Effects of peptide therapy on ex vivo T-cell responses. J Allergy Clin Immunol 1998; 101:506-13; PMID:9564804; http://dx.doi.org/10. 1016/S0091-6749(98)70358-6.
42. Pène J, Desroches A, Paradis L, Lebel B, Farce M, Nicodemus CF, et al. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J Allergy Clin Immunol 1998; 102:571-8; PMID:9802364; http://dx.doi.org/10.1016/S0091-6749(98)70294-5.
43. Zhu D, Kepley CL, Zhang K, Terada T, Yamada T, Saxon A. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat Med 2005; 11:446-9; PMID:15793580; http://dx.doi.org/10.1038/nm1219.
44. Terada T, Zhang K, Belperio J, Londhe V, Saxon A. A chimeric human-cat Fcgamma-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen. Clin Immunol 2006; 120:45-56; PMID:16473552; http://dx.doi.org/10.1016/j.clim.2005.12.010.
45. Hulse KE, Reefer AJ, Engelhard VH, Satinover SM, Patrie JT, Chapman MD, et al. Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy. J Allergy Clin Immunol 2008; 121:756-62, e4; PMID:18086491; http://dx.doi.org/10.1016/j.jaci.2007.10.016.
46. Andersson TN, Ekman GJ, Grönlund H, Buentke E, Eriksson TL, Scheynius A, et al. A novel adjuvantallergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitro. Immunology 2004; 113:253-9; PMID:15379986; http://dx.doi.org/10.1111/j.1365-2567.2004.01943.x.
47. Schmitz N, Dietmeier K, Bauer M, Maudrich M, Utzinger S, Muntwiler S, et al. Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy. J Exp Med 2009; 206:1941-55; PMID:19667059; http://dx.doi.org/10.1084/jem.20090199.
48. Moisan J, Camateros P, Thuraisingam T, Marion D, Koohsari H, Martin P, et al. TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am J Physiol Lung Cell Mol Physiol 2006; 290:L987-95; PMID:16361354; http://dx.doi.org/10.1152/ajplung.00440.2005.
49. Tournoy KG, Kips JC, Schou C, Pauwels RA. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy 2000; 30:79-85; PMID:10606934; http://dx.doi.org/10.1046/j.1365-2222.2000.00772. x.
50. Kwak YG, Song CH, Yi HK, Hwang PH, Kim JS, Lee KS, et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 2003; 111:1083-92; PMID:12671058.